Today's pre-market stock movers: K, SAVE, VALN, CHWY and more
Gainers:
• $Valneva(VALN.US$ +83.8% (Valneva SE and $Pfizer(PFE.US$ enter into an equity subscription agreement and update terms of collaboration agreement for VLA15)
• $Spirit Airlines(SAVE.US$ +8.8% (JetBlue (JBLU) submits proposal with increased offer of $33.50 per share in cash)
• $EJF Acquisition(EJFA.US$ +6.6% (shareholders approve proposed business combination with Pagaya Technologies; will trade on the Nasdaq under symbol "PGY")
• $New Residential Investment(NRZ.US$ +5.3% (to change its name and rebrand as Rithm Capital (RITM); now operates as an internally managed REIT)
• $Abiomed(ABMD.US$ +5% (entered into a new 10b5-l plan to continue repurchases of the Company's common stock under the Program)
• $Tremor International(TRMR.US$ +4.7% (confirms that it is currently in discussions with Amobee alongside a number of ongoing strategic discussions with other third parties)
• $Iris Energy(IREN.US$ +4.3% (re-iterated expected total online operating capacity of 3.7 EH/s by the end of Q3 2022)
• $Exact Sciences(EXAS.US$ +4.2% (entered a long-term supply agreement for Ultima's next-generation sequencing technologies)
• $Ocugen(OCGN.US$ +3.7% (Publication of Positive Results of COVID-19 Vaccine Trial for Children 2-18 in The Lancet Infectious Diseases)
• $Diamondback Energy(FANG.US$ +3.1% (announces further enhancement to its capital return program and intention to increase base dividend)
• $Scorpio Tankers(STNG.US$ +3.1% (President of the Company and Scorpio Holdings Limited a related party have purchased common shares of the Company in the open marke)
• $AstraZeneca(AZN.US$ +2% (Eplontersen met co-primary and secondary endpoints in interim analysis of the NEURO-TTRansform Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN))
• $Twitter (Delisted)(TWTR.US$ +1.7% (discloses that it recommends that shareholders vote for the adoption of the merger agreement)
• $JetBlue Airways(JBLU.US$ +1.4% (JetBlue (JBLU) submits proposal with increased offer of $33.50 per share in cash)
• $Frontier Group(ULCC.US$ +1.4% (JetBlue (JBLU) submits proposal with increased offer of $33.50 per share in cash)
• $Cronos Group(CRON.US$ +1.4% (Cronos Group and Ginkgo Bioworks (DNA) achieve THCV Equity Milestone; Cronos has issued to Ginkgo approximately 2.2 million common shares)
Analyst comments:
Losers:
• $ACADIA Pharmaceuticals(ACAD.US$ -32.1% (provides update from FDA Advisory Committee for NUPLAZID; concluded pimavanserin is ineffective for the treatment of hallucinations and delusions in the ADP population)
• $Rada Electronic(RADA.US$ -3% (RADA Electronic Industries & Leonardo DRS agree to all-stock merger combining top defense technology companies into leader in advanced sensing and force protection)
• $F45 Training(FXLV.US$ -1.1% (files for 18857319 share common stock offering by selling shareholders)
Analyst comments:
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
Shootingstar : AgEagle also up 75% pre market
71469986Andy : Okay baby I'm good
Carla Lee : was $40 ?